Pyxis Oncology (PYXS) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 15, 2026, to be held virtually for stockholders of record as of April 20, 2026.

• Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.

Voting matters and shareholder proposals

• Election of three Class II directors: Thomas Civik, Freda Lewis-Hall, M.D., and Michael A. Metzger.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Other business may be transacted as properly brought before the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends a vote in favor of the election of the three named Class II directors.